- 商品介绍
- 规格参数
- 包装参数
General description
The antibody DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
Immunogen
Fusion protein containing the extracellular part of TRAIL-R1 and the constant part of the heavy chain of the human IgG1.
Physical form
Solution in phosphate buffered saline with 15 mM sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
| biological source | mouse |
| conjugate | Allophycocyanin conjugate |
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| clone | DR-4-02, monoclonal |
| form | buffered aqueous solution |
| concentration | 0.1 mg/mL |
| technique(s) | flow cytometry: 1 μg/mL |
| accession no. | NP_003835 |
| shipped in | wet ice |
| storage temp. | 2-8°C |
| target post-translational modification | unmodified |
| Gene Information | human ... TNFRSF10A(8797) |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |




微信小程序
7X24小时在线咨询